Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,730 shares at $26.91 ($127K) on 2026-07-15, disclosed to the SEC on 2026-07-17.
Scheduled sale ($127k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |
| ARQT | SELL | 2026-04-03 | $239K | — | Filing → |